Delcath Systems(Stamford, Connecticut) said that Dr. Samuel Herschkowitz has resigned as a director of the company. Herschkowitz will continue to serve as a consultant to Delcath Systems through the end of the year in order to complete several key projects currently underway. Delcath Systems makes percutaneous perfusion technology for organ- or region-specific delivery of therapeutic and chemotherapeutic agents.

Dennis Goupil, PhD, was named senior VP of technical and Terence Vollrath was named VP of operations of Minrad International (Orchard Park, New York). Prior to joining Minrad, Goupil was the chief technical officer and VP of research and development at Biocure. Most recently, Vollrath was a consultant focusing on clients in the pharmaceuticals, chemicals, biotech and manufacturing industries. Minrad is an interventional pain management company with real-time image guidance, anesthesia and analgesia, and conscious sedation product lines.

Joseph Rafferty was named VP of sales for Pathway Medical Technologies (Kirkland, Washington). Rafferty previously held senior sales and marketing management positions at companies like ACS/Guidant. Pathway makes devices for the treatment of arterial disease.

• PlaCor (Plymouth, Minnesota) reported that John Reinke has been named CEO, effective Sept. 4. William Haworth has been promoted chief technology officer and will focus on the continued development of the company’s platelet reactivity testing technology. Reinke was most recently a senior VP for UnitedHealth group. PlaCor makes point-of-care tests to measure platelet reactivity.

No Comments